Back to Search Start Over

Structural Elements Directing G Proteins and β-Arrestin Interactions with the Human Melatonin Type 2 Receptor Revealed by Natural Variants.

Authors :
Plouffe B
Karamitri A
Flock T
Gallion JM
Houston S
Daly CA
Bonnefond A
Guillaume JL
Le Gouill C
Froguel P
Lichtarge O
Deupi X
Jockers R
Bouvier M
Source :
ACS pharmacology & translational science [ACS Pharmacol Transl Sci] 2022 Jan 25; Vol. 5 (2), pp. 89-101. Date of Electronic Publication: 2022 Jan 25 (Print Publication: 2022).
Publication Year :
2022

Abstract

G protein-coupled receptors (GPCRs) can engage distinct subsets of signaling pathways, but the structural determinants of this functional selectivity remain elusive. The naturally occurring genetic variants of GPCRs, selectively affecting different pathways, offer an opportunity to explore this phenomenon. We previously identified 40 coding variants of the MTNR1B gene encoding the melatonin MT <subscript>2</subscript> receptor (MT <subscript>2</subscript> ). These mutations differently impact the β-arrestin 2 recruitment, ERK activation, cAMP production, and Gα <subscript>i1</subscript> and Gα <subscript>z</subscript> activation. In this study, we combined functional clustering and structural modeling to delineate the molecular features controlling the MT <subscript>2</subscript> functional selectivity. Using non-negative matrix factorization, we analyzed the signaling signatures of the 40 MT <subscript>2</subscript> variants yielding eight clusters defined by unique signaling features and localized in distinct domains of MT <subscript>2</subscript> . Using computational homology modeling, we describe how specific mutations can selectively affect the subsets of signaling pathways and offer a proof of principle that natural variants can be used to explore and understand the GPCR functional selectivity.<br />Competing Interests: The authors declare the following competing financial interest(s): M.B. is the president of the scientific advisory Board of Domain Therapeutics which licensed-in some of the BRET-based biosensors, used in the present study, for their commercial use.<br /> (© 2022 The Authors. Published by American Chemical Society.)

Details

Language :
English
ISSN :
2575-9108
Volume :
5
Issue :
2
Database :
MEDLINE
Journal :
ACS pharmacology & translational science
Publication Type :
Academic Journal
Accession number :
35846981
Full Text :
https://doi.org/10.1021/acsptsci.1c00239